
International Meet on Women Health, Obstetrics and Gynecology (GYNEMEET2026)
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to International Meet on Women Health, Obstetrics and Gynecology (GYNEMEET2026) — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
International Meet on Women Health, Obstetrics and Gynecology (GYNEMEET2026) — Event Description
The International Meet on Women Health, Obstetrics and Gynecology (GYNEMEET2026) is a dedicated international gathering focused on improving outcomes in women’s health through advances in obstetrics, gynecology, maternal-fetal medicine, reproductive health, and evidence-based clinical practices. This platform brings together clinicians, researchers, academicians, policy influencers, healthcare administrators, and medical technology partners to share latest knowledge, discuss real-world clinical challenges, and accelerate adoption of innovations in women’s healthcare.
GYNEMEET2026 is designed as both a learning and collaboration forum—supporting knowledge exchange through conference sessions and expert discussions, while also enabling meaningful engagement between hospital leaders, professional medical communities, and industry stakeholders working on devices, diagnostics, pharmaceuticals, and women’s health services.
What the conference is known for
- Clinical education and expert-led learning: sessions that cover modern approaches to obstetrics and gynecology, with emphasis on safe, effective, and patient-centered care.
- Research, updates, and scientific exchange: a platform for presenting research findings, case-based discussions, and innovations aimed at improving maternal and reproductive outcomes.
- Interdisciplinary focus: women’s health is treated as a multi-disciplinary domain, bringing together related specializations involved in maternal care, reproductive medicine, diagnostics, and long-term health management.
- Industry and healthcare collaboration: opportunities for medical and healthcare organizations to connect with decision-makers across hospitals, specialist clinics, and academic institutions.
Audience and participant profile
We expect the event to attract a strong mix of participants including obstetricians and gynecologists, maternal-fetal medicine specialists, fertility and reproductive health experts, academic faculty, hospital and department administrators, clinical researchers, and representatives from women’s health organizations. In addition, the conference typically draws industry partners aligned with healthcare delivery, including providers of medical devices, diagnostic technologies, pharmaceutical and therapeutic solutions, and healthcare services that support women’s health programs.
Key themes and topics (high-level)
While final agenda details may vary by program track, GYNEMEET2026 is generally positioned around key women’s health priorities such as:
- Maternal health, pregnancy care, and risk management
- Obstetric care advancements and evidence-based clinical strategies
- Gynecological care, preventive health, and early diagnosis
- Reproductive health, fertility, and related clinical pathways
- Women’s healthcare diagnostics, imaging and clinical evaluation
- Minimally invasive approaches and surgical innovations
- Quality of care, patient safety, and clinical outcomes improvement
- Guidelines, standardization of care, and implementation strategies
- Healthcare access, women’s health programs, and awareness initiatives
Why we consider it valuable for healthcare stakeholders
GYNEMEET2026 supports professional advancement and operational improvement for organizations involved in women’s healthcare. For clinicians and researchers, it provides a place to exchange new learning and clinical strategies. For healthcare decision-makers and industry partners, it offers a focused, high-relevance environment to engage with specialist communities and align solutions with clinical needs in obstetrics and gynecology.
Overall, GYNEMEET2026 is structured to foster meaningful collaboration—helping participants connect knowledge with practice and enabling better care pathways for women across different healthcare settings.
Engagement format (expected)
- Scientific sessions and keynote discussions by subject-matter experts
- Panel discussions and interactive case-based learning
- Research presentations and knowledge-sharing formats
- Networking opportunities across clinicians, academics, and healthcare stakeholders
- Opportunities for industry participation aligned to women’s health needs
If we share your client’s website and product category, we can align the event’s buyer/attendee targeting more precisely by identifying the most relevant specialist hospital roles, medical leadership profiles, and healthcare decision-maker segments most likely to be interested in your offering.
Data sheet
| Event Name | International Meet on Women Health, Obstetrics and Gynecology (GYNEMEET2026) |
| Event Date | 27 October 2026 – 29 October 2026 |
| Event Status | Upcoming |
| Venue | Renaissance London Heathrow Hotel |
| City | London |
| State / Region | England |
| Country | United Kingdom |
| Organizer | Not publicly verified from primary sources in this environment |
| Official Event Website | Not publicly verified in this environment |
| Event Type | Medical conference / scientific meeting |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness; Education & Training |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low to Medium; current-year attendance data not publicly verified here |
| Main Purpose of Event | Knowledge exchange, clinical research discussion, professional networking, and solution discovery across women’s health, obstetrics, and gynecology. |
GYNEMEET2026 is positioned as a specialized international medical meeting focused on women’s health, obstetrics, and gynecology. The event is most relevant to clinicians, researchers, educators, hospital leaders, and healthcare vendors seeking visibility in a high-trust, clinical decision-making environment. As a topic-specific conference, it typically attracts professionals who influence treatment protocols, clinical purchasing, referrals, equipment selection, and continuing medical education.
The event matters because women’s health remains a high-priority area for innovation, service delivery, and patient outcomes across public and private healthcare systems. Its business relevance is strongest for medical device suppliers, diagnostics providers, pharma brands, fertility and maternal health services, hospital solutions vendors, and research organizations seeking engagement with specialist practitioners and institutional stakeholders.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| OB/GYN clinicians and department leads | Hospitals, women’s health clinics, university medical centers | Clinical evaluation, product preference, protocol influence | High for devices, diagnostics, therapeutics, education services |
| Maternal-fetal medicine and fertility specialists | Specialty practices, fertility centers, tertiary hospitals | Influence service adoption and patient pathways | High for IVF, ultrasound, monitoring, lab and diagnostic solutions |
| Hospital procurement and supply chain teams | NHS trusts, private hospitals, health systems | Purchasing, vendor qualification, contract negotiation | High for consumables, equipment, software, and service contracts |
| Nursing leaders, midwives, and clinical educators | Hospitals, maternity units, training institutions | Workflow adoption, training input, user feedback | Medium to High for workflow tools, patient care products, training content |
| Researchers and academics | Universities, research institutes, teaching hospitals | Evidence generation, study collaboration, protocol design | High for clinical trials, publishing, lab, and research vendors |
| Health system administrators and operations leaders | Hospitals, clinics, integrated care systems | Budget oversight, service expansion, vendor selection | Medium to High for clinical operations and patient-flow solutions |
| Pharma and medtech commercial teams | Manufacturers, distributors, brand owners | Partnerships, market access, medical education support | Medium for sponsorship, collaboration, and channel development |
| Public health and government representatives | Health ministries, public health agencies, maternal health programs | Policy input, program design, procurement oversight | Medium to High for population health, screening, and care delivery solutions |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: London | Local hospitals, clinics, universities, medtech suppliers | High | London is a major healthcare, research, and commercial hub. |
| Host region: England | NHS trusts, private hospital groups, medical schools | High | Strong domestic participation is likely due to specialty relevance and accessibility. |
| Nearby UK business hubs | Oxford, Cambridge, Birmingham, Manchester, Bristol | Medium to High | Relevant for clinical research, biotech, and hospital buying teams. |
| National reach: United Kingdom | Public and private healthcare buyers nationwide | High | Specialist medical conferences often draw a national professional audience. |
| International reach | Europe, Middle East, South Asia, Africa, North America | Medium to High | Global women’s health forums typically attract cross-border clinicians and suppliers. |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The topic, format, and specialty focus are suitable for international clinician, researcher, and supplier participation. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| NHS England | Government / healthcare buyer | Influences women’s health service design, adoption, and procurement across England. | nhs.uk | Procurement Director; Clinical Programme Lead; Medical Director | Strong Market Fit, Attendance Not Confirmed |
| Guy’s and St Thomas’ NHS Foundation Trust | Hospital buyer | Major London hospital with maternity and women’s health services. | gstt.nhs.uk | Head of Procurement; Consultant Obstetrician; Service Line Director | Strong Market Fit, Attendance Not Confirmed |
| Barts Health NHS Trust | Hospital buyer | Large tertiary-care trust with specialist women’s health demand. | bartshealth.nhs.uk | Procurement Manager; Maternity Services Lead; Clinical Director | Strong Market Fit, Attendance Not Confirmed |
| Imperial College Healthcare NHS Trust | Hospital / research buyer | Academic health system with clinical research and specialty services. | imperial.nhs.uk | Research Lead; Consultant Gynaecologist; Procurement Lead | Strong Market Fit, Attendance Not Confirmed |
| King’s College Hospital NHS Foundation Trust | Hospital buyer | Large maternity and specialist referral center in London. | kch.nhs.uk | Head of Women’s Health; Procurement Manager; Operations Director | Strong Market Fit, Attendance Not Confirmed |
| Chelsea and Westminster Hospital NHS Foundation Trust | Hospital buyer | Known for obstetrics, gynecology, and maternity services. | chelwest.nhs.uk | Maternity Lead; Consultant Obstetrician; Procurement Lead | Strong Market Fit, Attendance Not Confirmed |
| HCA Healthcare UK | Private hospital buyer | Private healthcare group with women’s health and fertility service interests. | hcahealthcare.co.uk | Procurement Director; Clinical Services Director; Fertility Service Lead | Strong Market Fit, Attendance Not Confirmed |
| Bupa | Healthcare payer / provider | Relevant for women’s health access pathways, clinics, and care coordination. | bupa.com | Clinical Procurement Lead; Medical Director; Partnerships Manager | Strong Market Fit, Attendance Not Confirmed |
| MSD (Merck Sharp & Dohme) | Pharmaceutical buyer / sponsor | Women’s health, vaccines, and clinical education relevance. | msd.com | Medical Affairs Director; Market Access Lead; Business Development Director | Strong Market Fit, Attendance Not Confirmed |
| RCOG – Royal College of Obstetricians and Gynaecologists | Professional association / influencer | Directly relevant professional body for the specialty community. | rcog.org.uk | Education Director; Policy Lead; Events Manager | Strong Market Fit, Attendance Not Confirmed |
| University College London Hospitals NHS Foundation Trust | Academic hospital buyer | Teaching hospital with research, specialty care, and procurement needs. | uclh.nhs.uk | Clinical Lead; Research Manager; Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| Ferring Pharmaceuticals | Pharmaceutical buyer / partner | Strong relevance to reproductive medicine and women’s health therapies. | ferring.com | Medical Affairs; Commercial Director; Partnerships Lead | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Medical Officer / Medical Director | Clinical Leadership | C-Level / SVP | Sets clinical priorities and influences high-value solution adoption. |
| 2 | Consultant Obstetrician / Consultant Gynaecologist | Clinical | Senior / Specialist | Direct user and clinical evaluator of products and practices. |
| 3 | Head of Women’s Health / Maternity Services Lead | Service Line Management | Director / Senior Manager | Owns service delivery, pathway changes, and vendor input. |
| 4 | Procurement Director / Procurement Manager | Procurement | Director / Manager | Controls buying decisions, vendor onboarding, and contracts. |
| 5 | Clinical Research Director / Research Manager | Research | Director / Manager | Relevant for trials, publications, and research partnerships. |
| 6 | Operations Director / Hospital Operations Lead | Operations | Director / Senior Manager | Influences service efficiency, workflow, and implementation. |
| 7 | Fertility Clinic Director / IVF Lead | Specialty Clinical | Director / Lead | High-fit for reproductive medicine products and services. |
| 8 | Medical Affairs Director / Market Access Manager | Pharma / Medtech | Director / Manager | Builds partnerships, education, and evidence-based adoption. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core buyer base for obstetrics and gynecology. | Hospitals, clinics, maternity units, specialty departments |
| 2 | Medical Practice | Independent specialists and group practices attend specialty conferences. | OB/GYN clinics, fertility practices |
| 3 | Pharmaceuticals | Drug brands and medical affairs teams target specialty clinicians. | Women’s health therapies, education, trials |
| 4 | Medical Devices | Diagnostics, monitoring, surgical, and imaging solutions are highly relevant. | Equipment, disposables, point-of-care tools |
| 5 | Biotechnology | Clinical research and reproductive science overlap strongly. | Trials, biomarkers, women’s health innovation |
| 6 | Research | Academic and translational research is a core event theme. | Collaborations, publications, grants |
| 7 | Higher Education | Medical schools and university hospitals influence specialty knowledge. | Faculty engagement, CME, research |
| 8 | Government Administration | Public health and maternal health programs may attend or source solutions. | Policy, screening, public care pathways |
| 9 | Health, Wellness & Fitness | Women’s wellness and preventive care stakeholders may be relevant. | Wellness services, patient education |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Confirmed unavailable | No verified current-year organizer disclosure available here | Use caution in forecasting list volume. |
| Exhibitor count | Not publicly confirmed | Confirmed unavailable | No verified exhibitor directory available here | Conference-style meetings may have limited exhibitor presence. |
| Buyer count | Not publicly confirmed | Confirmed unavailable | No verified buyer list available here | Likely mix of clinicians, researchers, and institutional buyers. |
| Speaker count | Not publicly confirmed | Confirmed unavailable | No verified agenda available here | Speaker count can materially affect lead quality if later published. |
| Historical attendance | Not publicly confirmed | Historical / prior-year evidence not verified here | No reliable prior-year official attendee list accessed here | Attendance figure not publicly confirmed by the organizer. |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Clinical education | Evidence-based updates and specialist training | Sponsorship, workshops, CME collaboration | Education platforms, speaker support, publishing |
| Maternal care | Improved outcomes, monitoring, workflow efficiency | Product demonstrations, clinical case discussions | Monitoring devices, maternity solutions, patient support |
| Gynecologic care | Diagnostics, procedures, treatment optimization | Clinical sessions and specialist networking | Imaging, surgical tools, diagnostics |
| Fertility and reproductive medicine | IVF pathway support and patient outcomes | Partnership outreach to specialists and clinics | IVF technologies, lab systems, medications |
| Research and innovation | Clinical evidence and new study participation | Research partnerships and investigator engagement | Trials support, analytics, lab products |
| Healthcare procurement | Approved suppliers, value-based purchasing | Direct meetings with procurement stakeholders | Equipment, consumables, software, services |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The event is tightly aligned to specialty healthcare buyers and influencers. |
| Decision-maker availability | High | Likely to include senior clinicians, service leads, and institutional stakeholders. |
| Data collection potential | Medium | Current-year attendee data not publicly verified here, limiting list precision. |
| Apollo targeting potential | Very High | Strong fit across hospitals, medical practices, pharma, and research organizations. |
| Geographic targeting potential | High | London provides a strong UK and international targeting base. |
| Best outreach approach | High-touch email, LinkedIn, and clinical partnership outreach | Message by specialty, service line, and buying pain point. |
| Overall lead quality | High | Useful for healthcare, medtech, pharma, education, and research lead generation. |
| Best use case | B2B attendee list building and specialty outreach | Best suited for solution providers selling into women’s health ecosystems. |
| Limitations / risks | Official event data not fully verified here | No confirmed current-year attendee, exhibitor, or agenda list accessed in this environment. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Practice; Pharmaceuticals; Medical Devices; Biotechnology; Research; Higher Education; Government Administration | Target the most relevant buyer ecosystems for the event. |
| Departments | Procurement; Clinical; Operations; Research; Medical Affairs; Partnerships | Reach buying and influencer teams. |
| Seniority | Manager; Director; VP; CXO; Owner / Partner where relevant | Prioritize decision-makers and budget holders. |
| Job titles | Procurement Director, Head of Women’s Health, Consultant Obstetrician, Maternity Services Lead, Medical Director, Clinical Research Director, Fertility Clinic Director, Medical Affairs Director | Pinpoint high-fit specialty and institutional buyers. |
| Geography | United Kingdom; London; England; Europe; Middle East; South Asia | Match likely event travel patterns and international participation. |
| Employee size | 51-200; 201-500; 501-1,000; 1,001-5,000; 5,001+ | Covers clinics through large hospital systems and multinationals. |
| Keywords | women’s health, obstetrics, gynecology, maternity, fertility, IVF, maternal care, reproductive health, prenatal, ultrasound | Refine searches to the exact specialty theme. |
| Technologies | Electronic medical records, telehealth, imaging, laboratory systems, patient engagement platforms | Useful if selling healthtech or workflow solutions. |
| Company type | Hospitals, clinics, academic medical centers, pharma companies, medtech manufacturers, public health bodies | Aligns search to likely attendees and buyers. |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| User-provided event brief | Event input | Event title, city, region, country, venue, and dates | High for supplied fields; not independently verified here |
| Renaissance London Heathrow Hotel official site | Venue website | Venue identity and location context | High |
| NHS | Government / healthcare system source | Healthcare buyer ecosystem relevance in England and the UK | High |
| Royal College of Obstetricians and Gynaecologists | Association / professional body | Specialty audience context and professional relevance | High |
| Official event website | Primary source not accessible in this environment | Could not be independently verified here for organizer, agenda, or attendee lists | Not verified in this environment |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to International Meet on Women Health, Obstetrics and Gynecology (GYNEMEET2026) — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.